Hypofrontality and negative symptoms in major depressive disorder.

UNLABELLED The purpose of the current study was to compare regional cerebral blood flow (rCBF) in patients with major depressive disorder (MDD) to that of healthy subjects and to examine the relationship between rCBF, depressive symptoms (DS) and negative symptoms (NS) in these patients. METHODS Eleven psychiatric inpatients with diagnosed (MDD) and 15 normal control subjects were administered the scale for the assessment of negative symptoms (SANS) and the modified Hamilton rating scale for depression with items descriptive of NS excluded (HRSD-DS). Each patient underwent a SPECT scan using 99mTc-HMPAO at rest. Cortical and subcortical regions of interest (ROIs) were symmetrically defined in each hemisphere. Cortical-to-cerebellar perfusion ratios were established quantitatively using ADAC software. RESULTS Subjects in the MDD group had significantly lower rCBF in the frontal cortex and cinglulate gyrus (MANOVA, p = 0.038) due to differences in dorsolateral prefrontal cortex bilaterally (right F = 7.69, p = 0.01; left F = 8.41, p = 0.01) in the right orbitofrontal cortex (F = 6.79, p = 0.02) and in the cingulate gyrus (F = 5.34, p = 0.03). The MDD group also had lower rCBF in the posterior cortical structures (MANOVA, p = 0.072), which was due to decreased perfusion in the right parietal cortex (F = 7.54, p = 0.01). There were negative correlations between the SANS total score and rCBF in both the left dorsolateral prefrontal cortex (Pearson's correlation coefficient r = .-67, p < 0.05) and the left anterior temporal cortex (r = -0.71, p < 0.01) in MDD patients. Additionally, there were positive correlations between HRSD scores and rCBF in the left anterior temporal (r = 0.71, p < 0.01), left dorsolateral prefrontal (r = 0.70, p < 0.01), right frontal (r = 0.82, p < 0.01) and right posterior temporal (r = 0.74, p < 0.01) cortices. Cerebral blood flow was not correlated with either mini-mental state examination scores or age. CONCLUSION This preliminary study replicates the finding of hypofrontality in MDD and indicates that decreased perfusion is associated specifically with negative symptom severity. These results support the hypothesis that, in MDD, negative symptoms and symptoms of depression are distinct phenomena and underscore the importance of negative symptom evaluation in neuroimaging studies of MDD and other disorders.

[1]  T. Higuchi,et al.  Regional cerebral blood flow in mood disorders , 1997 .

[2]  H. Lilliefors On the Kolmogorov-Smirnov Test for Normality with Mean and Variance Unknown , 1967 .

[3]  M S Buchsbaum,et al.  Brain glucose metabolism during non-rapid eye movement sleep in major depression. A positron emission tomography study. , 1996, Archives of general psychiatry.

[4]  H. Sackeim,et al.  Brain Imaging Studies of Depressive Disorders , 1993 .

[5]  S. Folstein,et al.  Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease , 1992, Neurology.

[6]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[7]  G. Rodriguez,et al.  Sex Differences in Regional Cerebral Blood Flow , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  S. Pappatà,et al.  Left prefrontal glucose hypometabolism in the depressed state: a confirmation. , 1990, The American journal of psychiatry.

[9]  H N Wagner,et al.  Paralimbic hypoperfusion in unipolar depression. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  P F Liddle,et al.  The Composition of the Negative Syndrome of Chronic Schizophrenia , 1993, British Journal of Psychiatry.

[11]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[12]  O Nickel,et al.  Regional cerebral blood flow in depression: associations with psychopathology. , 1989, Journal of affective disorders.

[13]  L. DeLisi,et al.  Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: Differences between normal controls and schizophrenic patients , 1987, Biological Psychiatry.

[14]  Karl J. Friston,et al.  The anatomy of melancholia – focal abnormalities of cerebral blood flow in major depression , 1992, Psychological Medicine.

[15]  J S Fowler,et al.  Reproducibility of regional brain metabolic responses to lorazepam. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  J. Brodie,et al.  Negative symptoms and hypofrontality in chronic schizophrenia. , 1992, Archives of general psychiatry.

[17]  M. Raichle,et al.  Neural correlates of self-induced dysphoria. , 1993, The American journal of psychiatry.

[18]  H. Mayberg,et al.  Clinical correlates of PET- and SPECT-identified defects in dementia. , 1994, The Journal of clinical psychiatry.

[19]  R. H. van den Hoofdakker,et al.  Total sleep deprivation on endogenous depression. , 1975, Archives of general psychiatry.

[20]  I. Galynker,et al.  Negative Symptoms in Patients With Alzheimer's Disease. , 1995, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[21]  J. Mazziotta,et al.  Reduction of prefrontal cortex glucose metabolism common to three types of depression. , 1989, Archives of general psychiatry.

[22]  A. Rush,et al.  Melancholic symptom features and DSM-IV. , 1994, The American journal of psychiatry.

[23]  R. Mathew,et al.  CEREBRAL BLOOD FLOW IN DEPRESSION , 1980, The Lancet.

[24]  J. Risberg,et al.  Acute and Late Effects of Electroconvulsive Therapy a , 1986 .

[25]  M. Buchsbaum,et al.  Functional and anatomical brain imaging: impact on schizophrenia research. , 1987, Schizophrenia bulletin.

[26]  I. Galynker,et al.  Negative symptoms in patients with major depressive disorder: a preliminary report. , 2000, Neuropsychiatry, neuropsychology, and behavioral neurology.

[27]  H. Mayberg,et al.  Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease , 1990, Annals of neurology.

[28]  A. Alavi,et al.  Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[30]  W. Jagust,et al.  Functional imaging in dementia: an overview. , 1994, The Journal of clinical psychiatry.

[31]  J. Risberg,et al.  Regional cerebral blood flow in depression and mania. , 1989, Archives of general psychiatry.

[32]  J. Mendlewicz,et al.  Regional Cerebral Blood Flow in Patients with Affective Disorders , 1990, British Journal of Psychiatry.

[33]  R. Rosenthal,et al.  Methylphenidate treatment of negative symptoms in patients with dementia. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[34]  N. Volkow,et al.  Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia. , 1987, The American journal of psychiatry.

[35]  M S Buchsbaum,et al.  Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. , 1986, Journal of affective disorders.

[36]  R Kawashima,et al.  Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  Karl J. Friston,et al.  Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity? , 1993, Journal of neurology, neurosurgery, and psychiatry.

[38]  S. Vorstrup,et al.  Effect of ECT on Cerebral Blood Flow in Melancholia Assessed with SPECT. , 1988, Convulsive therapy.

[39]  W. Burg,et al.  Total sleep deprivation on endogenous depression. , 1975, Archives of general psychiatry.

[40]  I. Liberzon,et al.  Measurement of depression and negative symptoms in schizophrenia. , 1992, Psychopathology.

[41]  M. Buchsbaum,et al.  Effect of sleep deprivation on brain metabolism of depressed patients. , 1992, The American journal of psychiatry.

[42]  L. DeLisi,et al.  Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. , 1984, Archives of general psychiatry.

[43]  M. Yonekawa,et al.  Regional Cerebral Blood Flow in Depression , 1990, The Japanese journal of psychiatry and neurology.

[44]  R. Dolan,et al.  Changes in regional cerebral blood flow on recovery from depression , 1995, Psychological Medicine.

[45]  R. Post,et al.  Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. , 1989, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[46]  N. Battistini,et al.  Regional cerebral blood flow changes following chronic administration of antidepressant drugs , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[47]  M E Raichle,et al.  Neuroanatomical circuits in depression: implications for treatment mechanisms. , 1992, Psychopharmacology bulletin.

[48]  D. Weinberger,et al.  Is the Mechanism of Prefrontal Hypofunction in Depression the Same as in Schizophrenia? , 1993, British Journal of Psychiatry.

[49]  L. DeLisi,et al.  Glucose utilization in the temporal cortex of affectively ill patients: Positron emission tomography , 1987, Biological Psychiatry.